Edit |   |
---|---|
Antigenic Specificity | CD147 (Meplazumab biosimilar) |
Clone | monoclonal |
Host Species | Recombinant Human |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | Protein A/G purified |
Size | 100 µg, 1 mg, |
Concentration | typically between 0.5-2.0 mg/ml. |
Applications | ELISA, WB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Meplazumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD147, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Meplazumab is a humanized anti-CD147 antibody that can competitively inhibit the binding of SP and CD147, prevent viruses from invading host cells, and provide a potential target for the development of antiviral drugs. |
Immunogen | n/a |
Other Names | Meplazumab, CD147 |
Gene, Accession # | n/a |
Catalog # | abx831578 |
Price | please inquire |
Order / More Info | CD147 (Meplazumab biosimilar) Antibody from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950